Galapagos is a clinical-stage biotechnology company specialized in the discovery and development of small molecule medicines with novel modes of action. Galapagos’ pipeline comprises Phase 3 through to discovery programs in cystic fibrosis, inflammation, fibrosis, osteoarthritis and other indications.
Galapagos is a clinical-stage biotechnology company specialized in the discovery and development of small molecule medicines with novel modes of action. Galapagos’ pipeline comprises Phase 3 through to discovery programs in cystic fibrosis, inflammation, fibrosis, osteoarthritis and other indications.
Your career starts on Magnet.me
Create a profile and receive connection requests from interested companies.
This company page was generated automatically and therefore features only limited information. Find out more about Galapagos on their company website:
This company page was generated automatically and therefore features only limited information. Find out more about Galapagos on their company website:
Change language to: Dutch
This page is optimised for people from the Netherlands. View the version optimised for people from the UK.